Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Artemisinin resistant falciparum malaria is an increasing problem in Southeast Asia, but has not been associated with increased transmission of the disease, yet. During a recent outbreak in 2014 in Ubon Ratchatani, Eastern Thailand, parasites from 101 patients with falciparum malaria were genotyped for antimalarial drug resistance markers. Mutations in the Kelch13 marker for artemisinin resistance were present in 93% of samples, mainly C580Y from 2 major clusters as identified by microsatellite typing. Resistance markers for antifolates and chloroquine were also highly prevalent. Most strains (91%) carried single copy number PfMDR1, suggesting sustained sensitivity to mefloquine, the partner drug in the local first-line artemisinin combination therapy (ACT). The high prevalence of artemisinin resistance in this recent malaria outbreak suggests but does not prove a causative role in increased transmission. Careful monitoring of ACT efficacy and additional genetic epidemiological studies are warranted to guide the public health response to the outbreak.

Original publication

DOI

10.1038/srep17412

Type

Journal article

Journal

Sci Rep

Publication Date

30/11/2015

Volume

5

Keywords

Adolescent, Adult, Antimalarials, Artemisinins, Cluster Analysis, Disease Outbreaks, Drug Resistance, Female, Gene Dosage, Genotype, Humans, Malaria, Falciparum, Male, Microsatellite Repeats, Molecular Typing, Mutation, Phylogeny, Plasmodium falciparum, Protozoan Proteins, Thailand, Young Adult